ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000266993.1	AKT inhibitor VIII	Bladder urothelial carcinoma	0.019614236	Resistant
ENSG00000266993.1	AKT inhibitor VIII	Liver hepatocellular carcinoma	0.042866001	Resistant